HLT:PA:PA-Lyxor Index Fund - Lyxor STOXX Europe 600 Healthcare UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 157.168

Change

0.00 (0.00)%

Market Cap

USD 0.77B

Volume

4.45K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.52 (+1.20%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.00 (-0.20%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

-0.04 (-0.13%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.62 (-0.26%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.45 (+0.32%)

USD 7.28B
HHH:PA HSBC ETFs Public Limited Compa..

-0.09 (-0.17%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.17 (-0.05%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.02 (-0.09%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.56 (-0.15%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

-0.39 (-0.37%)

USD 4.25B

ETFs Containing HLT:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.51% 82% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.51% 83% B 83% B
Trailing 12 Months  
Capital Gain 14.22% 68% D+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.22% 69% C- 73% C
Trailing 5 Years  
Capital Gain 63.27% 74% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.27% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 7.90% 60% D- 61% D-
Dividend Return 7.90% 61% D- 80% B-
Total Return N/A 52% F 59% D-
Risk Return Profile  
Volatility (Standard Deviation) 8.22% 71% C- 90% A-
Risk Adjusted Return 96.13% 92% A 96% N/A
Market Capitalization 0.77B 78% C+ 76% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike